A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...

ONE of the UK’s most common bugs almost triples the risk of death for a year after infection, scientists have discovered. For ...

A HORRIFIED dad has spoken of how he has watched not one daughter, but both fight for their lives in hospital. “It turns out ...

Ziresovir's Phase III results mark a significant milestone, representing the first clinical validation of an antiviral's ...

Clinical trials have shown that the RSV vaccine reduces symptoms by around 80 per cent, significantly lowering the risk of ...

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

Pregnant women's attitudes towards receiving the respiratory syncytial virus (RSV) vaccine to protect their newborn babies ...

The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial ...

The Allan Labor Government is backing a new study to boost the number of expectant mothers having the Respiratory Syncytial Virus (RSV) immunisation ...

Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...

Pope Francis was admitted to Rome’s Gemelli Hospital on Feb 14, 2025, with bronchitis, which later turned into double ...